Morten Baltzer Houlind

Morten Baltzer Houlind

Postdoc


Publication year:
All
26 - 33 out of 33Page size: 25
  1. 2022
  2. Published

    Further perspectives on statin use in patients with chronic kidney disease

    Houlind, Morten Baltzer, Iversen, E., Andersen, A., Juul-Larsen, H. G., Carlson, N., Andersen, Ove & Hornum, Mads, 2022, In: Basic and Clinical Pharmacology and Toxicology. 131, 5, p. 303-305

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Published

    Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]

    Houlind, Morten Baltzer, Iversen, E., Jawad, B. N., Kallemose, T. & Hornum, Mads, 2022, In: Clinical Epidemiology. 14, p. 763-764

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Comment on Delanaye et al: Future perspectives regarding kidney function estimates and dose adjustments

    Iversen, E., Hornum, Mads, Lund, Trine Meldgaard & Houlind, Morten Baltzer, 2022, In: British Journal of Clinical Pharmacology. 88, 6, p. 2998-2999

    Research output: Contribution to journal › Letter › Research › peer-review

  5. Published

    Comparison of 24-hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney disease

    Iversen, E., Boesby, L., Hansen, Ditte & Houlind, Morten Baltzer, 2022, In: Pharmacology Research & Perspectives. 10, 5, 5 p., e01002.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Performance of the Cockcroft-Gault, Modification of Diet in Renal Disease, and new Chronic Kidney Disease Epidemiology Collaboration equations without race in older acute medical patients

    Iversen, E., Bengaard, A. K., Andersen, A., Kallemose, T., Damgaard, Morten, Hornum, Mads, Feldt-Rasmussen, Bo, Andersen, Ove & Houlind, Morten Baltzer, 2022, In: Kidney International. 101, 5, p. 1087-1088

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease

    Iversen, E., Kallemose, T., Hornum, Mads, Bengaard, A. K., Nehlin, J. O., Rasmussen, L. J. H., Sandholdt, H., Tavenier, J., Feldt-Rasmussen, Bo, Andersen, Ove, Eugen-Olsen, J. & Houlind, Morten Baltzer, 2022, In: Clinical Kidney Journal. 15, 8, p. 1534-1541

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study

    Sharon, R., Lange, Theis, Aakjær, Mia, Brøgger Kristiansen, S., Houlind, Morten Baltzer & Andersen, Morten, 2022, In: European Journal of Clinical Pharmacology. 78, p. 1341–1349 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 283951172